menu
    • menu

    Find Quinapril manufacturers, exporters & distributors on PharmaCompass

    NEW Prospects: 1
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    15

    API Suppliers

    11

    USDMF

    4

    CEP/COS

    0

    JDMF

    3

    EU WC

    0

    KDMF

    4

    NDC API

    0

    VMF

    7

    Listed Suppliers

    5INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    3

    EDQM

    0

    USP

    0

    JP

    2

    Others

    FINISHED DOSAGE FORMULATIONS

    233

    FDF Dossiers

    77

    FDA Orange Book

    123

    Europe

    4

    Canada

    3

    Australia

    26

    South Africa

    0

    Listed Dossiers

    1PROSPECTS

    2DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    225RELATED EXCIPIENT COMPANIES

    370EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    8

    Health Canada Patents
    API/FDF Prices: Book a Demo

    API REF. PRICE (USD/KG)

    $
    $ 735

    GLOBAL SALES INFORMATION

    US Medicaid

    1,103,414

    Annual Reports

    NA

    Regulatory FDF Prices

    MARKET PLACE

    7

    API

    1

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    16

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 82586-55-8, Accupril, Quinapril hcl, Accuprin, Korec, Acequin
    Molecular Formula
    C25H31ClN2O5
    Molecular Weight
    475.0  g/mol
    InChI Key
    IBBLRJGOOANPTQ-JKVLGAQCSA-N
    FDA UNII
    33067B3N2M
    Quinapril
    A tetrahydroisoquinoline derivative and ANGIOTENSIN CONVERTING ENZYME inhibitor that is used in the treatment of HYPERTENSION and HEART FAILURE.
    1 2D Structure

    Quinapril

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride
    2.1.2 InChI
    InChI=1S/C25H30N2O5.ClH/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30;/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30);1H/t17-,21-,22-;/m0./s1
    2.1.3 InChI Key
    IBBLRJGOOANPTQ-JKVLGAQCSA-N
    2.1.4 Canonical SMILES
    CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl
    2.1.5 Isomeric SMILES
    CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    33067B3N2M
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid

    2. Accupril

    3. Ci 906

    4. Ci-906

    5. Pd 109,452 2

    6. Pd 109452 2

    7. Pd 109452-2

    8. Pd 1094522

    9. Pd-109,452-2

    10. Quinapril

    2.3.2 Depositor-Supplied Synonyms

    1. 82586-55-8

    2. Accupril

    3. Quinapril Hcl

    4. Accuprin

    5. Korec

    6. Acequin

    7. Quinazil

    8. Hemokvin

    9. Lidaltrin

    10. Acuitel

    11. Ectren

    12. Conan

    13. Quinapril (hydrochloride)

    14. Accupro

    15. Ci-906

    16. Quinapril.hcl

    17. Ci906

    18. Ci 906

    19. Quinaprilhydrochloride

    20. Quinapril Hydrochloride

    21. Nsc-758222

    22. Chebi:8714

    23. Quinapril Hydrochloride (accupril)

    24. 33067b3n2m

    25. (3s)-2-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1h-isoquinoline-3-carboxylic Acid;hydrochloride

    26. (s)-2-(((s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-l-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride

    27. (s)-2-((s)-n-((s)-1-carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid, 1-ethyl Ester, Monohydrochloride

    28. Accupron

    29. Acuprel

    30. Continucor

    31. Koretic

    32. Asig

    33. Dsstox_cid_1221

    34. Dsstox_rid_76019

    35. Dsstox_gsid_21221

    36. (s)-2-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride

    37. Cas-82586-55-8

    38. Quinapril Hydrochloride [usan]

    39. Hsdb 7046

    40. Pd 109452-2

    41. Unii-33067b3n2m

    42. Quinapril N-oxide

    43. Ncgc00094997-01

    44. Accupril (tn)

    45. Quinapril Hydrochloride [usan:usp]

    46. Mfcd00889215

    47. Quinapril Hydrochloride;

    48. Schembl41404

    49. Mls001076683

    50. Quinapril Hydrochloride ,(s)

    51. Spectrum1503076

    52. Quinapril Hydrochloride- Bio-x

    53. Quinapril For System Suitability

    54. Chembl1201011

    55. Dtxsid3021221

    56. Quinapril For Peak Identification

    57. Hms1922c15

    58. Pharmakon1600-01503076

    59. Tetrahydroisoquinoline-3-carboxylic

    60. Hy-b0477

    61. 2-ylamino)propanoyl)-1,2,3,4-

    62. Quinapril Hydrochloride [mi]

    63. Tox21_111381

    64. Tox21_200390

    65. Ccg-39543

    66. Nsc758222

    67. Quinapril Hydrochloride (jp17/usp)

    68. Quinapril Hydrochloride [jan]

    69. S2581

    70. Quinapril Hydrochloride [hsdb]

    71. Akos015888532

    72. Pd-109452-2

    73. Tox21_111381_1

    74. Ac-1655

    75. Nc00722

    76. Nsc 758222

    77. Quinapril Hydrochloride [mart.]

    78. Quinapril Hydrochloride [vandf]

    79. Quinapril Hydrochloride [usp-rs]

    80. Quinapril Hydrochloride [who-dd]

    81. Ncgc00167962-06

    82. Ncgc00257944-01

    83. (3s)-2-(n-{(1s)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-l-alanyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride

    84. (3s)-2-[(2s)-2-{[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride

    85. 3-isoquinolinecarboxylic Acid, 1,2,3,4-tetrahydro-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, Monohydrochloride, (3s-(2(r*(r*)),3r*))-

    86. 3-isoquinolinecarboxylic Acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, Monohydrochloride, (3s-(2(r*(r*)),3r*))

    87. As-14026

    88. Bq164301

    89. Smr000499582

    90. Pd-109522

    91. Pd109452-2

    92. Quinapril Hydrochloride [orange Book]

    93. Sw199393-2

    94. Quinapril Hydrochloride [ep Monograph]

    95. Quinapril Hydrochloride [usp Impurity]

    96. C07340

    97. D00459

    98. F20594

    99. Quinapril Hydrochloride [usp Monograph]

    100. Quinapril Hydrochloride, >=98% (hplc), Solid

    101. 586q558

    102. A840381

    103. Accuretic Component Quinapril Hydrochloride

    104. Quinaretic Component Quinapril Hydrochloride

    105. Sr-01000765404

    106. Sr-01000765404-2

    107. Q27108138

    108. Quinapril Hydrochloride Component Of Accuretic

    109. Quinapril Hydrochloride Component Of Quinaretic

    110. (s)-2-((s)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-

    111. Quinapril Hydrochloride, European Pharmacopoeia (ep) Reference Standard

    112. Quinapril Hydrochloride, United States Pharmacopeia (usp) Reference Standard

    113. Quinapril For Peak Identification, European Pharmacopoeia (ep) Reference Standard

    114. Quinapril For System Suitability, European Pharmacopoeia (ep) Reference Standard

    115. Quinapril Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

    116. (3s)-2-{(2s)-2-[(1s)-1-ethoxycarbonyl-3-phenylpropylamino]propanoyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride

    117. (3s)-2-{n-[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-l-alanyl}-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride

    118. 2-(2-((1-ethoxycarbonyl-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid Monohydrochloride(3s-(2(r*(r*)),3r*)

    2.4 Create Date
    2004-09-16
    3 Chemical and Physical Properties
    Molecular Weight 475.0 g/mol
    Molecular Formula C25H31ClN2O5
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count10
    Exact Mass474.1921498 g/mol
    Monoisotopic Mass474.1921498 g/mol
    Topological Polar Surface Area95.9 Ų
    Heavy Atom Count33
    Formal Charge0
    Complexity648
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 6  
    Drug NameAccupril
    PubMed HealthQuinapril (By mouth)
    Drug ClassesAntihypertensive, Cardiovascular Agent, Renal Protective Agent
    Drug LabelACCUPRIL (quinapril hydrochloride) is the hydrochloride salt of quinapril, the ethyl ester of a non-sulfhydryl, angiotensin-converting enzyme (ACE) inhibitor, quinaprilat.Quinapril hydrochloride is chemically described as [3S-[2[R*(R*)], 3R*]]-2-[2...
    Active IngredientQuinapril hydrochloride
    Dosage FormTablet
    RouteOral
    Strengtheq 40mg base; eq 5mg base; eq 20mg base; eq 10mg base
    Market StatusPrescription
    CompanyPfizer Pharms

    2 of 6  
    Drug NameAccuretic
    PubMed HealthQuinapril/Hydrochlorothiazide (By mouth)
    Drug ClassesACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent
    Active IngredientHydrochlorothiazide; quinapril hydrochloride
    Dosage FormTablet
    RouteOral
    Strength25mg; eq 20mg base; eq 10mg base; 12.5mg
    Market StatusPrescription
    CompanyPfizer Pharms

    3 of 6  
    Drug NameQuinapril hydrochloride
    Drug LabelQuinapril hydrochloride is the hydrochloride salt of quinapril, the ethyl ester of a non-sulfhydryl, angiotensin-converting enzyme (ACE) inhibitor, quinaprilat.Quinapril hydrochloride is chemically described as [3S-[2[R*(R*)], 3R*]]-2-[2-[[1-(ethox...
    Active IngredientQuinapril hydrochloride
    Dosage FormTablet
    RouteOral
    Strengtheq 5mg base; eq 20mg base; eq 40mg base; eq 10mg base
    Market StatusPrescription
    CompanyRanbaxy; Actavis Labs Fl; Teva; Aurobindo Pharma; Sun Pharm Inds; Lupin; Invagen Pharms; Mylan

    4 of 6  
    Drug NameAccupril
    PubMed HealthQuinapril (By mouth)
    Drug ClassesAntihypertensive, Cardiovascular Agent, Renal Protective Agent
    Drug LabelACCUPRIL (quinapril hydrochloride) is the hydrochloride salt of quinapril, the ethyl ester of a non-sulfhydryl, angiotensin-converting enzyme (ACE) inhibitor, quinaprilat.Quinapril hydrochloride is chemically described as [3S-[2[R*(R*)], 3R*]]-2-[2...
    Active IngredientQuinapril hydrochloride
    Dosage FormTablet
    RouteOral
    Strengtheq 40mg base; eq 5mg base; eq 20mg base; eq 10mg base
    Market StatusPrescription
    CompanyPfizer Pharms

    5 of 6  
    Drug NameAccuretic
    PubMed HealthQuinapril/Hydrochlorothiazide (By mouth)
    Drug ClassesACE Inhibitor/Thiazide Combination, Antihypertensive, Cardiovascular Agent
    Active IngredientHydrochlorothiazide; quinapril hydrochloride
    Dosage FormTablet
    RouteOral
    Strength25mg; eq 20mg base; eq 10mg base; 12.5mg
    Market StatusPrescription
    CompanyPfizer Pharms

    6 of 6  
    Drug NameQuinapril hydrochloride
    Drug LabelQuinapril hydrochloride is the hydrochloride salt of quinapril, the ethyl ester of a non-sulfhydryl, angiotensin-converting enzyme (ACE) inhibitor, quinaprilat.Quinapril hydrochloride is chemically described as [3S-[2[R*(R*)], 3R*]]-2-[2-[[1-(ethox...
    Active IngredientQuinapril hydrochloride
    Dosage FormTablet
    RouteOral
    Strengtheq 5mg base; eq 20mg base; eq 40mg base; eq 10mg base
    Market StatusPrescription
    CompanyRanbaxy; Actavis Labs Fl; Teva; Aurobindo Pharma; Sun Pharm Inds; Lupin; Invagen Pharms; Mylan

    4.2 Therapeutic Uses

    ... /Quinapril/ has proven to be very useful for the treatment of hypertension ... . /Salt not specified/

    Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 893

    The angiotensin converting enzyme (ACE) inhibitors appear to confer a special advantage in the treatment of patients with diabetes, slowing the development of diabetic glomerulopathy. They also have been shown to be effective in slowing the progression of other forms of chronic renal disease, such as glomerulosclerosis, & many of these patients also have hypertension. An ACE inhibitor is probably the preferred initial agent in the treatment of hypertensive patients with left ventricular hypertrophy. Patients with hypertension & ischemic heart disease are candidates for treatment with ACE inhibitors; this includes treatment in the immediate post-myocardial infarction period which has been shown to lead to improved ventricular function & reduced morbidity & mortality. /ACE inhibitors/ /Salt not specified/

    Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 893

    The combination of ... quinapril and hydrochlorothiazide is indicated in the treatment of hypertension. Fixed-dosage combinations generally are not recommended for initial therapy, but are utilized in maintenance therapy after the required dose is established in order to increase convenience, economy, and patient compliance. /Included in US product labeling/ /Salt not specified/

    MICROMEDEX Thomson Health Care. USPDI - Drug Information for the Health Care Professional. 22nd ed. Volume 1. MICROMEDEX Thomson Health Care, Greenwood Village, CO. 2002. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 215

    Angiotensin converting enzyme (ACE) inhibitor /Salt not specified/

    O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 1441

    For more Therapeutic Uses (Complete) data for QUINAPRIL HYDROCHLORIDE (6 total), please visit the HSDB record page.

    4.3 Drug Warning

    Reduce dose ... in patients with serum creatinine > or =221 umol/L (2.5 mg/dL). /ACE Inhibitors; from table/ /Salt not specified/

    Ellenhorn, M.J., S. Schonwald, G. Ordog, J. Wasserberger. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins, 1997., p. 553

    May cause hyperkalemia in patients with renal impairment or in those receiving potassium-sparing agents. /ACE Inhibitors; from table/ /Salt not specified/

    Ellenhorn, M.J., S. Schonwald, G. Ordog, J. Wasserberger. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins, 1997., p. 553

    Can cause acute renal failure in patients with severe bilateral renal artery stenosis or severe stenosis in artery to solitary kidney. /ACE Inhibitors; from table/ /Salt not specified/

    Ellenhorn, M.J., S. Schonwald, G. Ordog, J. Wasserberger. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins, 1997., p. 553

    Conversion of quinapril to quinaprilat is reduced in patients with diminished liver function. /Salt not specified/

    Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 824

    For more Drug Warnings (Complete) data for QUINAPRIL HYDROCHLORIDE (12 total), please visit the HSDB record page.

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Angiotensin-Converting Enzyme Inhibitors

    A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    Cardiovascular Agents

    Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. (See all compounds classified as Cardiovascular Agents.)

    5.2 FDA Pharmacological Classification
    5.2.1 Pharmacological Classes
    Angiotensin-converting Enzyme Inhibitors [MoA]; Angiotensin Converting Enzyme Inhibitor [EPC]
    5.3 Absorption, Distribution and Excretion

    Absorption (bioavailability) of quinapril is 60%; time to peak serum concn is 2 hr; half-life (elimination) is 2 hr; protein binding is 97%; metabolism is in the liver. /from table/ /Salt not specified/

    Ellenhorn, M.J., S. Schonwald, G. Ordog, J. Wasserberger. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins, 1997., p. 557

    Quinapril is rapidly absorbed (peak concns are achieved in 1 hr, but the peak may be delayed after food), & its rate but not extent of oral absorption (60%) may be reduced by food. Quinapril is metabolized to quinaprilat & to other minor metabolites, & quinaprilat is excreted in the urine (61%) & the feces (37%). Peak concns of quinaprilat in plasma are achieved in about 2 hr. Conversion of quinapril to quinaprilat is reduced in patients with diminished liver function. The initial half-life of quinaprilat is about 2 hr; a prolonged terminal half-life of about 25 hr may be due to high-affinity binding of the drug to tissue ACE. /Salt not specified/

    Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 823

    5.4 Metabolism/Metabolites

    Cleavage of the ester moiety by hepatic esterases transforms quinapril hydrochloride, a prodrug, into quinaprilat, an ACE inhibitor that in vitro is about as potent as benazeprilat. ... Quinapril is metabolized to quinaprilat & to other minor metabolites ... .

    Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 823

    5.5 Biological Half-Life

    The initial half-life of /the metabolite/ quinaprilat is about 2 hr; a prolonged terminal half-life of about 25 hr may be due to high-affinity binding of the drug to tissue ACE. /Salt not specified/

    Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 824

    5.6 Mechanism of Action

    Block formation of angiotensin II, promoting vasodilation & decreased aldosterone; also increased bradykinin & vasodilatory prostaglandins. /ACE Inhibitors; from table/ /Salt not specified/

    Ellenhorn, M.J., S. Schonwald, G. Ordog, J. Wasserberger. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins, 1997., p. 553

    Quinapril is deesterified to the principal metabolite, quinaprilat, which is an inhibitor of ACE activity in human subjects and animals. ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II. The effect of quinapril in hypertension and in congestive heart failure (CHF) appears to result primarily from the inhibition of circulating and tissue ACE activity, thereby reducing angiotensin II formation. Quinapril inhibits the elevation in blood pressure caused by iv administered angiotensin I, but has no effect on the pressor response to angiotensin II, norepinephrine or epinephrine. Angiotensin II also stimulates the secretion of aldosterone from the adrenal cortex, thereby facilitating renal sodium and fluid reabsorption. Reduced aldosterone secretion by quinapril may result in a small incr in serum potassium. In controlled hypertension trials, treatment with ACCUPRIL alone resulted in mean increases in potassium of 0.07 mmol/L ... . Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity (PRA). /Salt not specified/

    Medical Economics Co; Physicians Desk Reference 56th ed p.2611 (2002)

    API SUPPLIERS

    read-more
    read-more

    01

    LGM Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DCAT Week
    The Lexington Hotel
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Aarti Pharmalabs

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    DCAT Week
    The Benjamin Royal Sonesta
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2021-01-07

    Pay. Date : 2020-12-31

    DMF Number : 19413

    Submission : 2006-05-08

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2016-100 - Rev 00

    Issue Date : 2023-02-01

    Type : Chemical

    Substance Number : 1763

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-08-22

    Valid Till : 2028-08-21

    Written Confirmation Number : WC-0099

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 15308-0500

    Start Marketing Date : 1992-01-01

    End Marketing Date : 2026-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

     KDMF VMF Others AUDIT arrow-down
    Aarti Industries Company Banner

    03

    HRV Pharma

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Arab Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU, MX, ... arrow-down
    ✖
    Available Reg Filing : AU, MX, ASMF
    AUDIT
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Willow Birch Pharma

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Arab Health
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Zhejiang Huahai Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Arab Health
    Not Confirmed
    arrow

    Zhejiang Huahai Pharmaceutical

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Arab Health
    Not Confirmed
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-07-23

    Pay. Date : 2012-11-23

    DMF Number : 20315

    Submission : 2006-10-17

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2013-102 - Rev 02

    Issue Date : 2020-09-16

    Type : Chemical

    Substance Number : 1763

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Lupin Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    CPhI Milan
    Exhibiting
    arrow

    Lupin Ltd

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI Milan
    Exhibiting
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17957

    Submission : 2004-12-31

    Status : Active

    Type : II

     CEP/COS JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2025-10-08

    Valid Till : 2028-07-04

    Written Confirmation Number : WC-0202

    Address of the Firm :

    NDC KDMF VMF Others AUDIT arrow-down
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Viatris

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Arab Health
    Not Confirmed
    arrow

    Viatris

    U.S.A

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Arab Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21476

    Submission : 2008-03-22

    Status : Inactive

    Type : II

     CEP/COS Inactive-api
    ✖

    Certificate Number : R0-CEP 2012-411 - Rev 02

    Issue Date : 2017-09-18

    Type : Chemical

    Substance Number : 1763

    Status : Withdrawn by Holder

     JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Signa S.A. de C.V.

    Mexico

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Arab Health
    Not Confirmed
    arrow

    Signa S.A. de C.V.

    Mexico

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Arab Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15619

    Submission : 2001-09-14

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Sun Pharmaceutical Industries Limi...

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Arab Health
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limi...

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Arab Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21751

    Submission : 2008-07-18

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Solara Active Pharma Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Arab Health
    Not Confirmed
    arrow

    Solara Active Pharma Sciences

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Arab Health
    Not Confirmed
    USDMF Inactive-api
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20333

    Submission : 2007-03-08

    Status : Inactive

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-moreread-more

    01

    Aarti Pharmalabs Ltd

    India
    arrow
    DCAT Week
    The Benjamin Royal Sonesta
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : Complete

    Rev. Date : 2021-01-07

    Pay. Date : 2020-12-31

    DMF Number : 19413

    Submission : 2006-05-08

    Status : Active

    Type : II

    Aarti Industries Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Arab Health
    Not Confirmed

    02

    Apitoria Pharma Private Ltd

    India
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 19046

    Submission : 2005-11-30

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Esteve Quimica Sa

    Spain

    USDMF

    arrow
    Arab Health
    Not Confirmed

    03

    Esteve Quimica Sa

    Spain
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 12471

    Submission : 1997-04-14

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Farmhispania Sa

    Spain

    USDMF

    arrow
    Arab Health
    Not Confirmed

    04

    Farmhispania Sa

    Spain
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16735

    Submission : 2003-07-25

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Lupin Ltd

    India
    arrow
    CPhI Milan
    Exhibiting

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17957

    Submission : 2004-12-31

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Signa Sa De Cv

    Mexico

    USDMF

    arrow
    Arab Health
    Not Confirmed

    06

    Signa Sa De Cv

    Mexico
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15619

    Submission : 2001-09-14

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Arab Health
    Not Confirmed

    07

    Solara Active Pharma Sciences Ltd

    India
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20333

    Submission : 2007-03-08

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Arab Health
    Not Confirmed

    08

    Sun Pharmaceutical Industries Ltd

    India
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21751

    Submission : 2008-07-18

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Arab Health
    Not Confirmed

    09

    Sun Pharmaceutical Industries Ltd

    India
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 16261

    Submission : 2002-11-27

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Arab Health
    Not Confirmed

    10

    Mylan Laboratories Ltd

    U.S.A
    arrow
    Arab Health
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 21476

    Submission : 2008-03-22

    Status : Inactive

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Suppliers

    read-more
    read-more

    01

    LGM Pharma

    U.S.A
    arrow
    DCAT Week
    The Lexington Hotel
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Quinapril

    About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for pharmaceutical and biotech industries. LGM also operates as a full-service CDMO, offering formulat...

    LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for pharmaceutical and biotech industries. LGM also operates as a full-service CDMO, offering formulation, analytical method development and testing, custom API synthesis, regulatory support, and commercial manufacturing. Supported by a network of over 300 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    LGM Pharma CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Aarti Pharmalabs

    India
    arrow
    DCAT Week
    The Benjamin Royal Sonesta
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothAarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Quinapril

    About the Company : Aarti Pharmalabs is generic APIs & Intermediates manufacturing company & small molecule drug substance CDMO and the largest Indian manufacturer of Xanthine Derivatives (Caffeine, e...

    Aarti Pharmalabs is generic APIs & Intermediates manufacturing company & small molecule drug substance CDMO and the largest Indian manufacturer of Xanthine Derivatives (Caffeine, etc.). It has dedicated facilities to manufacture HPAPIs, corticosteroids, cytotoxic & oncology products. It has 3 R&D centers and 3 cGMP plants successfully audited by the USFDA, EUGMP, EDQM, KFDA & COFEPRIS. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
    Aarti Industries Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    HRV Pharma

    India
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Quinapril

    About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

    HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    HRV Global Life Sciences

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Willow Birch Pharma

    U.S.A
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Quinapril

    About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

    Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
    Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Aurobindo Pharma Limited

    India
    World Health Expo
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Quinapril

    About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...

    Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Farmhispania

    Spain
    World Health Expo
    Not Confirmed
    arrow

    Farmhispania

    Spain
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Quinapril

    About the Company : Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipmen...

    Farmhispania Group comprises two companies in Spain: Farmhispania in Barcelona and Rolabo in Zaragoza. Since its inception, the group has consistently invested in advanced equipment, new technologies, and enhanced capabilities. Significant investments include the implementation of hydrogenation technologies in 2007, HPAPI handling capabilities in 2010, highly potent fermentation capabilities in 2014, and the expansion of large-scale preparative chromatography in 2015. Additionally, Farmhispania Group actively collaborates on numerous projects with various universities and research organizations both nationally and internationally.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Zhejiang Huahai Pharmaceutical

    China
    World Health Expo
    Not Confirmed
    arrow

    Zhejiang Huahai Pharmaceutical

    China
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Quinapril

    About the Company : Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceu...

    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648405800,"product":"QUINAPRIL HYDROCHLORIDE PH.EUR(PHARMACEU","address":"71, UDYOG KSHETRA, 2nd FLOOR, MULUND GOREGAON LINK ROAD, MULUND (","city":"MUMBAI","supplier":"AARTI INDUSTRIES LTD","supplierCountry":"INDIA","foreign_port":"AMSTERDAM, SCHIPHOL","customer":"NEELE VAT AIR BV","customerCountry":"NETHERLANDS","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"727.5","totalValueFC":"143532.8","currency":"USD","unitRateINR":54700,"date":"28-Mar-2022","totalValueINR":"10940000","totalValueInUsd":"143532.8","indian_port":"BOMBAY AIR","hs_no":"29221990","bill_no":"9283141","productDescription":"API","marketType":"REGULATED MARKET","country":"NETHERLANDS","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"71, UDYOG KSHETRA, 2nd FLOOR, MULUND GOREGAON LINK ROAD, MULUND (, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678386600,"product":"QUINAPRIL HCL (PHARMACEUTICAL RAW MATERI","address":"2ND FLOOR, GODOWN NO. 204 UDYOG KSHETRA, MULUND GOREGAON LINK","city":"MUMBAI","supplier":"AARTI PHARMALABS LTD","supplierCountry":"INDIA","foreign_port":"BASLE","customer":"CREDIT SUISSE","customerCountry":"SWITZERLAND","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"1000.9","totalValueFC":"5799.4","currency":"USD","unitRateINR":79500,"date":"10-Mar-2023","totalValueINR":"477000","totalValueInUsd":"5799.4","indian_port":"BOMBAY AIR","hs_no":"29221990","bill_no":"8365650","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"2ND FLOOR, GODOWN NO. 204 UDYOG KSHETRA, MULUND GOREGAON LINK, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722450600,"product":"QUINAPRIL HYDROCHLORIDE USP (PHARMACEUTICAL RAW MATERIALS)(INV NO: PEX\/0409\/24-25 DT. 22.07.2024)","address":"2ND FLOOR, GODOWN No. 204","city":"MUMBAI","supplier":"AARTI PHARMALABS LTD","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"TO ORDER","customerCountry":"EGYPT","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"997.5","totalValueFC":"1803","currency":"USD","unitRateINR":75618,"date":"01-Aug-2024","totalValueINR":"151236","totalValueInUsd":"1803","indian_port":"Bombay Air","hs_no":"29221990","bill_no":"2889333","productDescription":"API","marketType":"","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"2ND FLOOR, GODOWN No. 204, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731263400,"product":"PHARMACEUTICAL RAW MATERIALS:QUINAPRIL HYDROCHLORIDE PH.EUR.(QUINAPRIL HYDROCHLORIDE)[INV.NO.PEX\/0844\/24-25 DT.06.11.24]","address":"2ND FLOOR, GODOWN No. 204","city":"MUMBAI","supplier":"AARTI PHARMALABS LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"TO ORDER","customerCountry":"RUSSIA","quantity":"1.80","actualQuantity":"1.8","unit":"KGS","unitRateFc":"150696","totalValueFC":"3005.9","currency":"INR","unitRateINR":140924.98888888888,"date":"11-Nov-2024","totalValueINR":"253664.98","totalValueInUsd":"3005.9","indian_port":"Bombay Air","hs_no":"29221990","bill_no":"5506071","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"2ND FLOOR, GODOWN No. 204, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1756319400,"product":"QUINAPRIL BENZYL ESTER MALEATE SALT (INTERMEDIATE) CAS NO. :- 82586-54-7 BATCH NO.AHL-CDMO-3387-220","address":"N\/A","city":"N\/A","supplier":"APISYN HEALTHCARE PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"LLC VELPHARM","customerCountry":"RUSSIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"300000","totalValueFC":"1571.1","currency":"INR","unitRateINR":275000,"date":"28-Aug-2025","totalValueINR":"137500","totalValueInUsd":"1571.1","indian_port":"Ahmedabad Air","hs_no":"29420090","bill_no":"4799806","productDescription":"Intermediate","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"N\/A, N\/A","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1759084200,"product":"QUINAPRIL BENZYL ESTER MALEATE SALT,BATCH NO.AHL-CDMO-3387- 566","address":"N\/A","city":"N\/A","supplier":"APISYN HEALTHCARE PRIVATE LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"LLC VELPHARM","customerCountry":"RUSSIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"280000","totalValueFC":"2945.5","currency":"INR","unitRateINR":260000,"date":"29-Sep-2025","totalValueINR":"260000","totalValueInUsd":"2945.5","indian_port":"Ahmedabad Air","hs_no":"29420090","bill_no":"5733389","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Ahmedabad Air","supplierAddress":"N\/A, N\/A","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646850600,"product":"QUINAPRIL HYDROCHLORIDE","address":"11TH FLR.GRANDEUR,OPP.GUNDECHA,SYM PHONY, VEERA DESAI RD.EXTENSION","city":"MUMBAI SUBURBAN,MAHARASHTRA","supplier":"TEVA PHARMA NEW ZEALAND LTD","supplierCountry":"SPAIN","foreign_port":"NA","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"226.83","actualQuantity":"226.83","unit":"KGS","unitRateFc":"600","totalValueFC":"153026.4","currency":"EURO","unitRateINR":"51420","date":"10-Mar-2022","totalValueINR":"11663598.6","totalValueInUsd":"153026.4","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"7812936","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"11TH FLR.GRANDEUR,OPP.GUNDECHA,SYM PHONY, VEERA DESAI RD.EXTENSION"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664217000,"product":"QUINAPRIL HYDROCHLORIDE","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"1250","totalValueFC":"6270.2","currency":"USD","unitRateINR":"100500","date":"27-Sep-2022","totalValueINR":"502500","totalValueInUsd":"6270.2","indian_port":"BOMBAY AIR","hs_no":"29221990","bill_no":"2629544","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664821800,"product":"158-20-0005 QUINAPRIL HYDROCHLORIDE","address":"11TH FLR.GRANDEUR,OPP.GUNDECHA,SYM PHONY, VEERA DESAI RD.EXTENSION","city":"MUMBAI SUBURBAN,MAHARASHTRA","supplier":"TEVA PHARMA NEW ZEALAND LTD","supplierCountry":"SPAIN","foreign_port":"NA","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"360.25","actualQuantity":"360.25","unit":"KGS","unitRateFc":"750","totalValueFC":"265314","currency":"EURO","unitRateINR":"60600","date":"04-Oct-2022","totalValueINR":"21831150","totalValueInUsd":"265314","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"2738925","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"11TH FLR.GRANDEUR,OPP.GUNDECHA,SYM PHONY, VEERA DESAI RD.EXTENSION"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695666600,"product":"158-20-0005 QUINAPRIL HYDROCHLORIDE BATCH 158001031","address":"11TH FLOOR, LOTUS BUSINESS PARK,","city":"MUMBAI,MAHARASHTRA","supplier":"TEVA PHARMA NEW ZEALAND LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"240.00","actualQuantity":"240","unit":"KGS","unitRateFc":"650","totalValueFC":"157957.9","currency":"USD","unitRateINR":"54632.5","date":"26-Sep-2023","totalValueINR":"13111800","totalValueInUsd":"157957.9","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"8005744","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"41 SHORTLAND STREET AUCKLANDSDNFSDNF New Zealand","customerAddress":"11TH FLOOR, LOTUS BUSINESS PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709490600,"product":"QUINAPRIL HYDROCHLORIDE","address":"11TH FLOOR, LOTUS BUSINESS PARK,","city":"MUMBAI,MAHARASHTRA","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"NINGBO","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"207.50","actualQuantity":"207.5","unit":"KGS","unitRateFc":"650","totalValueFC":"165067.6","currency":"USD","unitRateINR":"66055.5","date":"04-Mar-2024","totalValueINR":"13706520.14","totalValueInUsd":"165067.6","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"2413977","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NINGBO","supplierAddress":"XUNQIAO LINHAI ZHEJIANG 317024,CHINASDNF China","customerAddress":"11TH FLOOR, LOTUS BUSINESS PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733769000,"product":"158-20-0005 QUINAPRIL HYDROCHLORIDE (BATCH NO: 5454-24-008) 158-20-0005 QUINAPRIL HYDROCHLORIDE (BATCH NO: 5454-24-008)","address":"11TH FLOOR, LOTUS BUSINESS PARK,","city":"MUMBAI,MAHARASHTRA","supplier":"TEVA PHARMA NEW ZEALAND LTD","supplierCountry":"CHINA","foreign_port":"NINGBO","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"118.50","actualQuantity":"118.5","unit":"KGS","unitRateFc":"650","totalValueFC":"77642.3","currency":"USD","unitRateINR":"55672.5","date":"10-Dec-2024","totalValueINR":"6597191.25","totalValueInUsd":"77642.3","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"7155566","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NINGBO","supplierAddress":"41 SHORTLAND STREET AUCKLAND NEW ZE ALAND SDNF New Zealand","customerAddress":"11TH FLOOR, LOTUS BUSINESS PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1750185000,"product":"QUINAPRIL RELATED COMPOUND B (QTY:1 X 50 MG; VALUE: USD 903)(FOC)SAMPLES FOR IN HOUSE R&D\/TESTING PURPOSE","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"UNITED STATES PHARMACOPEIAL CONVENTION","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIAINDIA PRIVATE LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00005","unit":"KGS","unitRateFc":"18372740","totalValueFC":"927.5","currency":"USD","unitRateINR":"1593835000","date":"18-Jun-2025","totalValueINR":"79691.75","totalValueInUsd":"927.5","indian_port":"Hyderabad Air","hs_no":"29334990","bill_no":"2738926","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK, MD, US 21704, UNITED STATES OF AMER ICA United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1757874600,"product":"(158-20-0005) QUINAPRIL HYDROCHLORIDE (BATCH NO: 5454-25-001)(158-20-0005) QUINAPRIL HYDROCHLORIDE (BATCH NO 5454-25-001","address":"11TH FLOOR, LOTUS BUSINESS PARK,","city":"MUMBAI,MAHARASHTRA","supplier":"TEVA PHARMA NEW ZEALAND LTD","supplierCountry":"CHINA","foreign_port":"NINGBO","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"110.50","actualQuantity":"110.5","unit":"KGS","unitRateFc":"650","totalValueFC":"72419.8","currency":"USD","unitRateINR":"57850","date":"15-Sep-2025","totalValueINR":"6392425","totalValueInUsd":"72419.8","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4516465","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NINGBO","supplierAddress":"41 SHORTLAND STREET AUCKLAND NEW ZEALAND C\/O ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD NZ","customerAddress":"11TH FLOOR, LOTUS BUSINESS PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q4","strtotime":1765477800,"product":"(158-20-0005) QUINAPRIL HYDROCHLORIDE (BATCH 5454-25-001) (158-20-0005) QUINAPRIL HYDROCHLORIDE (BATCH 5454-25-001)","address":"11TH FLOOR, LOTUS BUSINESS PARK,","city":"MUMBAI,MAHARASHTRA","supplier":"TEVA PHARMA NEW ZEALAND LTD","supplierCountry":"CHINA","foreign_port":"NINGBO","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"96.60","actualQuantity":"96.6","unit":"KGS","unitRateFc":"650","totalValueFC":"63696.3","currency":"USD","unitRateINR":"59345","date":"12-Dec-2025","totalValueINR":"5732727","totalValueInUsd":"63696.3","indian_port":"Bombay Air","hs_no":"29334990","bill_no":"14","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NINGBO","supplierAddress":"41 SHORTLAND STREET AUCKLAND NEW ZEALAND SDNF NZ","customerAddress":"11TH FLOOR, LOTUS BUSINESS PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q4","strtotime":1765477800,"product":"(158-20-0005) QUINAPRIL HYDROCHLORIDE (BATCH 5454-25-001) (158-20-0005) QUINAPRIL HYDROCHLORIDE (BATCH 5454-25-001)","address":"11TH FLOOR, LOTUS BUSINESS PARK,","city":"MUMBAI,MAHARASHTRA","supplier":"TEVA PHARMA NEW ZEALAND LTD","supplierCountry":"CHINA","foreign_port":"NINGBO","customer":"MARKSANS PHARMA LTD","customerCountry":"INDIA","quantity":"108.00","actualQuantity":"108","unit":"KGS","unitRateFc":"650","totalValueFC":"71213.3","currency":"USD","unitRateINR":"59345","date":"12-Dec-2025","totalValueINR":"6409260","totalValueInUsd":"71213.3","indian_port":"Bombay Air","hs_no":"29334990","bill_no":"14","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NINGBO","supplierAddress":"41 SHORTLAND STREET AUCKLAND NEW ZEALAND SDNF NZ","customerAddress":"11TH FLOOR, LOTUS BUSINESS PARK,"}]
    10-Mar-2022
    12-Dec-2025
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    FDA Orange Book

    read-more
    read-more

    01

    ACTAVIS LABS FL INC

    Ireland
    World Health Expo
    Not Confirmed
    arrow

    ACTAVIS LABS FL INC

    Ireland
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 20MG BASE

    Approval Date : 2005-01-14

    Application Number : 76049

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS ELIZABETH

    Ireland
    World Health Expo
    Not Confirmed
    arrow

    ACTAVIS ELIZABETH

    Ireland
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 10MG BASE

    Approval Date : 2004-12-22

    Application Number : 76459

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ANI PHARMS

    U.S.A
    World Health Expo
    Not Confirmed
    arrow

    ANI PHARMS

    U.S.A
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 20MG BASE

    Approval Date : 2007-08-24

    Application Number : 75504

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    APOTEX

    Canada
    World Health Expo
    Not Confirmed
    arrow

    APOTEX

    Canada
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 25MG;EQ 20MG BASE

    Approval Date : 2013-03-12

    Application Number : 91524

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    INVAGEN PHARMS

    U.S.A
    World Health Expo
    Not Confirmed
    arrow

    INVAGEN PHARMS

    U.S.A
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 40MG BASE

    Approval Date : 2007-08-24

    Application Number : 78457

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    INVAGEN PHARMS

    U.S.A
    World Health Expo
    Not Confirmed
    arrow

    INVAGEN PHARMS

    U.S.A
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 12.5MG;EQ 20MG BASE

    Approval Date : 2011-04-20

    Application Number : 201356

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    PFIZER PHARMS

    U.S.A
    World Health Expo
    Not Confirmed
    arrow

    PFIZER PHARMS

    U.S.A
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    QUINAPRIL HYDROCHLORIDE

    Brand Name : ACCUPRIL

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Approval Date : 1991-11-19

    Application Number : 19885

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    PRINSTON INC

    U.S.A
    World Health Expo
    Not Confirmed
    arrow

    PRINSTON INC

    U.S.A
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code : AB

    QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 20MG BASE

    Approval Date : 2016-09-15

    Application Number : 205823

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    SUN PHARM INDS LTD

    India
    World Health Expo
    Not Confirmed
    arrow

    SUN PHARM INDS LTD

    India
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : 12.5MG;EQ 20MG BASE

    Approval Date : 2009-03-04

    Application Number : 78211

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    PHARMOBEDIENT

    Country
    World Health Expo
    Not Confirmed
    arrow

    PHARMOBEDIENT

    Country
    arrow
    World Health Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : No

    TE Code :

    QUINAPRIL HYDROCHLORIDE

    Brand Name : QUINAPRIL HYDROCHLORIDE

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 10MG BASE

    Approval Date : 2004-12-23

    Application Number : 76694

    RX/OTC/DISCN : DISCN

    RLD : No

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - TABLET;ORAL - EQ 10MG BASE **Federal...DOSAGE - TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 19885

    read-more

    DOSAGE - TABLET;ORAL - EQ 20MG BASE **Federal...DOSAGE - TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 19885

    read-more

    DOSAGE - TABLET;ORAL - EQ 40MG BASE **Federal...DOSAGE - TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 19885

    read-more

    DOSAGE - TABLET;ORAL - EQ 5MG BASE **Federal ...DOSAGE - TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    USFDA APPLICATION NUMBER - 19885

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Granulation

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Vegetarian Capsules

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Looking for 82586-55-8 / Quinapril API manufacturers, exporters & distributors?

    Quinapril manufacturers, exporters & distributors 1

    47

    PharmaCompass offers a list of Quinapril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Quinapril manufacturer or Quinapril supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Quinapril manufacturer or Quinapril supplier.

    PharmaCompass also assists you with knowing the Quinapril API Price utilized in the formulation of products. Quinapril API Price is not always fixed or binding as the Quinapril Price is obtained through a variety of data sources. The Quinapril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Quinapril

    Synonyms

    82586-55-8, Accupril, Quinapril hcl, Accuprin, Korec, Acequin

    Cas Number

    82586-55-8

    Unique Ingredient Identifier (UNII)

    33067B3N2M

    About Quinapril

    A tetrahydroisoquinoline derivative and ANGIOTENSIN CONVERTING ENZYME inhibitor that is used in the treatment of HYPERTENSION and HEART FAILURE.

    Accupro Manufacturers

    A Accupro manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Accupro, including repackagers and relabelers. The FDA regulates Accupro manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Accupro API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Accupro manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Accupro Suppliers

    A Accupro supplier is an individual or a company that provides Accupro active pharmaceutical ingredient (API) or Accupro finished formulations upon request. The Accupro suppliers may include Accupro API manufacturers, exporters, distributors and traders.

    click here to find a list of Accupro suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Accupro USDMF

    A Accupro DMF (Drug Master File) is a document detailing the whole manufacturing process of Accupro active pharmaceutical ingredient (API) in detail. Different forms of Accupro DMFs exist exist since differing nations have different regulations, such as Accupro USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Accupro DMF submitted to regulatory agencies in the US is known as a USDMF. Accupro USDMF includes data on Accupro's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Accupro USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Accupro suppliers with USDMF on PharmaCompass.

    Accupro CEP

    A Accupro CEP of the European Pharmacopoeia monograph is often referred to as a Accupro Certificate of Suitability (COS). The purpose of a Accupro CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Accupro EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Accupro to their clients by showing that a Accupro CEP has been issued for it. The manufacturer submits a Accupro CEP (COS) as part of the market authorization procedure, and it takes on the role of a Accupro CEP holder for the record. Additionally, the data presented in the Accupro CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Accupro DMF.

    A Accupro CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Accupro CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of Accupro suppliers with CEP (COS) on PharmaCompass.

    Accupro WC

    A Accupro written confirmation (Accupro WC) is an official document issued by a regulatory agency to a Accupro manufacturer, verifying that the manufacturing facility of a Accupro active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Accupro APIs or Accupro finished pharmaceutical products to another nation, regulatory agencies frequently require a Accupro WC (written confirmation) as part of the regulatory process.

    click here to find a list of Accupro suppliers with Written Confirmation (WC) on PharmaCompass.

    Accupro NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Accupro as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Accupro API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Accupro as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Accupro and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Accupro NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Accupro suppliers with NDC on PharmaCompass.

    Accupro GMP

    Accupro Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Accupro GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Accupro GMP manufacturer or Accupro GMP API supplier for your needs.

    Accupro CoA

    A Accupro CoA (Certificate of Analysis) is a formal document that attests to Accupro's compliance with Accupro specifications and serves as a tool for batch-level quality control.

    Accupro CoA mostly includes findings from lab analyses of a specific batch. For each Accupro CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Accupro may be tested according to a variety of international standards, such as European Pharmacopoeia (Accupro EP), Accupro JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Accupro USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search